189 related articles for article (PubMed ID: 30956647)
1. Effect of cerebral dopamine neurotrophic factor on endogenous neural progenitor cell migration in a rat model of Parkinson's disease.
Nasrolahi A; Mahmoudi J; Karimipour M; Akbarzadeh A; Sadigh-Eteghad S; Salehi R; Farajdokht F; Farhoudi M
EXCLI J; 2019; 18():139-153. PubMed ID: 30956647
[TBL] [Abstract][Full Text] [Related]
2. Cerebral dopamine neurotrophic factor increases proliferation, Migration and differentiation of subventricular zone neuroblasts in photothrombotic stroke model of mouse.
Shabani Z; Soltani Zangbar H; Nasrolahi A
J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106725. PubMed ID: 36116218
[TBL] [Abstract][Full Text] [Related]
3. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
4. Intraventricular administration of endoneuraminidase-N facilitates ectopic migration of subventricular zone-derived neural progenitor cells into 6-OHDA lesioned striatum of mice.
Li C; Zhang YX; Yang C; Hao F; Chen SS; Hao Q; Lu T; Qu TY; Zhao LR; Duan WM
Exp Neurol; 2016 Mar; 277():139-149. PubMed ID: 26724216
[TBL] [Abstract][Full Text] [Related]
5. Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats.
Belzunegui S; Izal-Azcárate A; San Sebastián W; Garrido-Gil P; Vázquez-Claverie M; López B; Marcilla I; Luquin MR
Brain Res; 2008 Jun; 1217():213-20. PubMed ID: 18502401
[TBL] [Abstract][Full Text] [Related]
6. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
Wang L; Wang Z; Zhu R; Bi J; Feng X; Liu W; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
PLoS One; 2017; 12(6):e0179476. PubMed ID: 28622392
[TBL] [Abstract][Full Text] [Related]
8. Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease.
Voutilainen MH; Bäck S; Peränen J; Lindholm P; Raasmaja A; Männistö PT; Saarma M; Tuominen RK
Exp Neurol; 2011 Mar; 228(1):99-108. PubMed ID: 21185834
[TBL] [Abstract][Full Text] [Related]
9. Korean Red Ginseng Enhances Neurogenesis in the Subventricular Zone of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice.
Ryu S; Jeon H; Koo S; Kim S
Front Aging Neurosci; 2018; 10():355. PubMed ID: 30459594
[TBL] [Abstract][Full Text] [Related]
10. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
Jiaming M; Niu C
Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
[TBL] [Abstract][Full Text] [Related]
11. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
[TBL] [Abstract][Full Text] [Related]
12. Sleep deprivation disrupts striatal anti-apoptotic responses in 6-hydroxy dopamine-lesioned parkinsonian rats.
Ahmadian N; Mahmoudi J; Talebi M; Molavi L; Sadigh-Eteghad S; Rostrup E; Ziaee M
Iran J Basic Med Sci; 2018 Dec; 21(12):1289-1296. PubMed ID: 30627374
[TBL] [Abstract][Full Text] [Related]
13. Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra.
Albert K; Renko JM; Mätlik K; Airavaara M; Voutilainen MH
Front Neurosci; 2019; 13():590. PubMed ID: 31244598
[TBL] [Abstract][Full Text] [Related]
14. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats.
Urakawa S; Hida H; Masuda T; Misumi S; Kim TS; Nishino H
Neuroscience; 2007 Feb; 144(3):920-33. PubMed ID: 17161913
[TBL] [Abstract][Full Text] [Related]
15. Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling.
Singh S; Mishra A; Bharti S; Tiwari V; Singh J; Parul ; Shukla S
Mol Neurobiol; 2018 Aug; 55(8):6500-6517. PubMed ID: 29327199
[TBL] [Abstract][Full Text] [Related]
16. Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson's Disease.
Huotarinen A; Penttinen AM; Bäck S; Voutilainen MH; Julku U; Piepponen TP; Männistö PT; Saarma M; Tuominen R; Laakso A; Airavaara M
Neuroscience; 2018 Mar; 374():250-263. PubMed ID: 29408408
[TBL] [Abstract][Full Text] [Related]
17. MANF Promotes Differentiation and Migration of Neural Progenitor Cells with Potential Neural Regenerative Effects in Stroke.
Tseng KY; Anttila JE; Khodosevich K; Tuominen RK; Lindahl M; Domanskyi A; Airavaara M
Mol Ther; 2018 Jan; 26(1):238-255. PubMed ID: 29050872
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.
Bäck S; Peränen J; Galli E; Pulkkila P; Lonka-Nevalaita L; Tamminen T; Voutilainen MH; Raasmaja A; Saarma M; Männistö PT; Tuominen RK
Brain Behav; 2013 Mar; 3(2):75-88. PubMed ID: 23532969
[TBL] [Abstract][Full Text] [Related]
19. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
eNeuro; 2017; 4(1):. PubMed ID: 28303260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
